Percheron Therapeutics LimitedASX: PER

US FDA Grants RPDD to ATL1102 for the treatment of DMD

Sep 30, 2020 at 4:16 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment